Japanese encephalitis (JE) virus, a mosquito-borne flavivirus, is the most common vaccine preventable cause of encephalitis in Asia. Biovalys has launched a new chromatographically purified Vero cell inactivated Japanese encephalitis vaccines (CVI-JE) in 2015. The clinical study of this new CVI-JE vaccine among Thai children showed good immunogenicity and safety. A new novel Enterovirus 71 (EV71) and typhoid conjugate vaccines, and a preservative-free inactivated hepatitis A vaccine are also under registration while several new pediatric combined vaccines shall also be made available in Thailand.